Sai Charan Labishetty

Mr. Sai Charan Labishetty

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2017 in Acta Ophthalmologica
Verified
Journal Article
Open access
PDF file
LKLilian Hui Li Koh
Lilian Hui Li Koh
RARupesh Agrawal
Rupesh Agrawal
NKNeha Khandelwal
Neha Khandelwal
Sai Charan LabishettySai Charan Labishetty
Sai Charan Labishetty
Jay ChhablaniJay Chhablani
Jay Chhablani
Purpose: To assess the choroidal vascular changes using choroidal vascularity index (CVI) in patients with age‐related macular degeneration (AMD) compared to controls.Methods: Enhanced depth imaging (EDI) optical coherence tomography (OCT) scans of 64 patients with unilateral or bilateral AMD were obtained. Images with a poorly demarcated choroidal–scleral interface (CSI) were excluded from the analysis. Foveal scans of 63 AMD eyes and 35 ‘normal fellow’ eyes were analysed. Images of 30 eyes from 18 age‐matched healthy subjects were included as controls. Choroidal vascularity index (CVI) was derived from binarization of EDI OCT images, using fiji software.Results: The mean age was 56.50 ± 5.50 years for AMD patients and 52.25 ± 6.75 years for controls. All patients were treatment naïve. Subfoveal choroidal thickness (SFCT) in AMD, ‘normal fellow’ eyes and controls was 314.02 ± 78.80 μm, 300.88 ± 53.85 μm and 278.5 ± 65.31 μm, respectively. Choroidal vascularity index (CVI) in AMD, ‘normal fellow’ eyes and controls was 64.04 ± 2.43%, 64.66 ± 2.25% and 66.07 ± 1.72%, respectively. Choroidal vascularity index (CVI) of both AMD and ‘normal fellow’ eyes was significantly lower compared to controls (p < 0.0001 and p = 0.007). The SFCT of AMD eye was not found to be significantly different from ‘normal fellow eyes’ (p = 0.45).Conclusion: There was no statistical difference in SFCT, but CVI was significantly lower in patients with AMD. Choroidal vascularity index (CVI) was also lower in ‘normal fellow’ AMD eyes as compared to controls. This suggests possible reduction in choroidal vascularity in eyes with AMD and also to a certain extent in the ‘normal fellow’ eyes without phenotypical manifestations and may suggest underlying choroidal morphological change leading to wet AMD.

18 July 2022 in International Journal of Health Sciences and Research
Verified
Journal Article
Closed access
SKSalal Khan
Salal Khan
TRTara Rani
Tara Rani
SFSana Falak
Sana Falak
Sai Charan LabishettySai Charan Labishetty
Sai Charan Labishetty
Aim/Purpose: The purpose of this study is to assess the prevalence of diabetic retinopathy and its associated factors among diabetic patients at Goyal Eye Institute, New Delhi. Methodology: A cross-sectional descriptive study was conducted among diabetic patients. A total of 345 (mean age: 47±2.53 years) participants- male=192 & female=153, were enrolled in this study. They were selected through systematic sampling procedure. Explanatory data were extracted from medical records and interviews. Blood pressure (BP), Blood sugar, weight, height, and visual acuity and refraction tests were assessed. Retinal examination was performed with a Forus (3nethra) fundus camera. All the collected data was processed and analysed by Chi-square test in SPSS version 21. Results: It was found that out of 345 subjects, 86 (24.9%) had Diabetic retinopathy (DR). Among the diabetic retinopathy patients, 68.4% had the pre-proliferative type. Five in ten (46.3%) of the patients had visual acuity problems and showing DR symptoms. Poor glycemic control (95% CI 1.46–2.41), > 10 years’ diabetes duration (95% CI 1.68–3.64), >20 years’ diabetes duration (95% CI 1.88–2.72), body-mass index >25 kg/m2 (95% CI 1.32–3.54), and hypertension (95% CI 1.44–2.62), smoking (95% CI 1.93-2.58) were factors significantly associated with diabetic retinopathy. All factors mentioned were found to be statistically significant (p<0.05) with the Pearson Chi-square in SPSS version 21. Conclusion: This study shows about a-fifth of diabetic patients had diabetic retinopathy. Risk factors of Diabetic retinopathy were significantly associated with poor glycemic control, hypertension, body-mass index (obesity), and duration or onset of illness. Routine blood sugar assessment as well as eye examination and early control of those associated factors may be important in reducing both the prevalence and impact of diabetic retinopathy. Key words: Eye-care services, Diabetic retinopathy, Avoidable blindness, Diabetes mellitus .

20 July 2022 in International Journal of Scientific Research in Science and Technology
Verified
Journal Article
Open access
PDF file
AKAjeeta Kumari
Ajeeta Kumari
TRTara Rani
Tara Rani
NKNiranjan Kumar
Niranjan Kumar
SKSalal Khan
Salal Khan
Sai Charan LabishettySai Charan Labishetty
Sai Charan Labishetty
ICE syndrome (iris corneal endothelium syndrome) is a rare condition that affects the irregular corneal endothelium, which can cause varying degrees of glaucoma. The proliferative and structural abnormalities of the corneal endothelium, the increasing constriction of the iridocorneal angle, and iris abnormalities such atrophy, correctopia, and polycoria are the hallmarks of the ICE syndrome. A Narrative review was done to review the articles available on PubMed, Google Scholar, Medline, Publon, Orcid, Healthstar, and others related to ICE syndrome. Peer-reviewed articles/ studies were referred to ascertain the available screening tests, risk factors, physiological parameters, and diagnosis of glaucoma on the basis of ICE, chandler’s syndrome, progressive iris atrophy and management options for ICE syndrome. This review study provides an overview of the ICE syndrome’s complications, ocular examination, causes and about management options. Thus, the assessment can be easily done by full ophthalmic workup, with vision assessment of refractive error, slit lamp examination, intraocular pressure measurement, and fundus examination. In Gonioscopy findings we will get PAS usually extending to or beyond the schwalbe line. It is yet unknown what factors underlie corneal endothelial changes and are the primary causes of ICE syndrome. A viral aetiology has been proposed, particularly Epstein virus and Herpes simplex virus. The initial step in treating corneal oedema is to lower the intraocular pressure inside the eye.

24 February 2026 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
AFAazima Fatima
Aazima Fatima
TRTara Rani
Tara Rani
Sai Charan LabishettySai Charan Labishetty
Sai Charan Labishetty
HDHitesh Kumar Dewangan
Hitesh Kumar Dewangan
Introduction: Autorefraction is fast, yet accommodation can distort pediatric measurements, and cycloplegic refraction minimizes accommodation and therefore could be more suitable for functional eyesight. The correlation between the readings of the autorefractometer, cycloplegic refraction, and the subjective acceptance was systematically reviewed in children aged between 6 and 15 years. Methods: Following PRISMA, PubMed, Scopus, and Web of Science were searched (20002024) in search of studies comparing the outcomes of autorefraction, cycloplegic refraction, and/or subjective refraction in children. Risk of bias (QUADAS-2) was assessed using duplicate assessment of eligibility and data extraction. Results: In all the suitable studies, cycloplegic refraction demonstrated the best correlation with the ultimate subjective acceptance and delivered hyperopia estimates that were more accurate in comparison to noncycloplegic cycloplegic autorefractive refraction. Non-cycloplegic autorefraction was more likely to overmyopia/ under-hyperopia in younger children. It was in agreement more when autorefraction was done under cycloplegia and in the old subgroups. Discussion: Since accommodation is dynamic in the pediatric population, non-cycloplegic autorefraction alone is insufficient to misclassify the refractive status. The association of autorefraction with cycloplegia is enhanced in precision and performance, whereas the subjective refinement is fundamental towards comfort and compliance. Conclusion: Parents of the 6- to 15-year-old age group children rely most on cycloplegic refraction as a source of prescription, with autorefraction being utilised most optimally under cycloplegia or as a screening measure followed by cycloplegic confirmation and age-adjusted additional subjective refinement.

9 October 2025 in Indian Journal of Science and Technology
Verified
Journal Article
Open access
PDF file
Sai Charan LabishettySai Charan Labishetty
Sai Charan Labishetty
VMVandana Mahaur
Vandana Mahaur
HTHimanshu Tripathi
Himanshu Tripathi
Objectives: This trial conducted a comparison between once-nightly instillation of 0.01% atropine eye drops and placebo to suppress axial elongation of progressive myopia in adolescents. Method: A parallel, randomised, double-masked, placebo-controlled superiority trial was conducted at a single university centre. Adolescents (12–18 years) with progressive myopia were assigned to 0.01% atropine or placebo and followed for 18 months. Axial length was measured using swept-source optical biometry (IOLMaster 700) at baseline, 6, 12, and 18 months. Eye-level longitudinal mixed-effects modelling with baseline adjustment assessed treatment effects. Supportive measures included refraction, safety monitoring, and adherence checks. The trial was prospectively registered on the Clinical Trials Registry–India (CTRI ID: REF/2023/04/102943). Findings: At 18 months, the mean change in axial-length was +0.21 0.10 mm in atropine group versus +0.40 0.12 mm in placebo, giving adjusted between-group difference of -0.19 mm (p < 0.05). The differences became apparent in Month 6 and lasted up to Month 18. The paralleled axial-length results change to those of the spherical-equivalent refraction. Adherence was 93-94% and adverse events were mild (transient photophobia and near blur) with no discontinuations. Novelty: To date, fewer than five randomised, placebo-controlled trials worldwide have specifically evaluated low-dose atropine in adolescents, and only a subset employed axial length as the primary outcome. This study adds quantitative evidence that nightly 0.01% atropine provides structural protection against axial elongation with high tolerability, supporting its use as a first-line pharmacologic option in adolescent myopia control. Keywords: Myopia Control, Axial Length, Atropine 0.01%, Mixed-Effects Model, Randomised Controlled Trial

8 October 2026 in Saudi Journal of Ophthalmology
Verified
Journal Article
Closed access
Sai Charan LabishettySai Charan Labishetty
Sai Charan Labishetty
DNDinesh K. Nagula
Dinesh K. Nagula
LBLogesh Babu
Logesh Babu
Was not provided for this article.